Skip to main content
TipRanks
Go Ultimate75% OFF

Precision System Science Co.,Ltd (7707) AI Stock Analysis

1 Followers
JP:7707

Precision System Science Co.,Ltd

(TSE/TYO:7707)

Select Model
Rating:61Neutral
Price Target:JPY 192.00â–²(0.00% Upside)
Action:reiterated
Date:08/19/26

The overall score of 61 reflects a company in the midst of a recovery. The most significant positive factor is the operational turnaround and a now-healthy balance sheet. The most significant risk, and the primary drag on the score, is the severe disconnect between reported profitability and actual cash generation, which raises concerns about the sustainability of the recovery. Technicals are mildly supportive, and the valuation is fair.

Positive Factors
Laboratory automation platformThe company operates in laboratory automation, serving clinical and research workflows that benefit from standardized, high-throughput processing. Its platforms and related consumables can support recurring usage and deepen integration with customer procedures, creating a durable foundation beyond one-time equipment sales.
Negative Factors
Weak cash conversionThe large gap between reported net income and operating cash flow indicates that earnings are not currently converting efficiently into cash. Negative free cash flow can increase dependence on external funding and constrain investment or shareholder returns if this pattern persists.

Precision System Science Co.,Ltd (7707) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%50%JP:7707-4.95%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.27B
Dividend Yield
1.04%
Average Volume (3M)
142.32K
Price to Earnings (P/E)
13.3
Beta (1Y)
1.01
Revenue Growth
9.27%
EPS Growth
―
Country
Japan
Employees
129
Sector
General
Sector Strength
55
Industry
Medical - Diagnostics & Research

Precision System Science Co.,Ltd Business Overview & Revenue Model

Company Description

Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese do...

Precision System Science Co.,Ltd Financial Statement Overview

Summary

The company has achieved a strong operational turnaround with revenue growth and a return to net profitability, while significantly de-risking its balance sheet by reducing debt. However, the financial health is undermined by extremely poor cash flow conversion, with negligible operating cash flow and negative free cash flow despite reported profits, indicating low earnings quality.

Income Statement

68Positive

Balance Sheet

72Positive

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue5.22B5.22B4.69B3.98B5.28B7.43B
Gross Profit1.58B1.58B1.38B950.38M1.35B2.49B
EBITDA411.95M409.05M10.06M-661.75M-594.05M740.33M
Net Income394.87M394.87M-253.10M-1.12B-1.32B45.34M
Balance Sheet
Total Assets5.85B5.85B4.94B6.40B9.76B11.41B
Cash, Cash Equivalents and Short-Term Investments1.37B1.37B1.04B1.92B2.45B2.76B
Total Debt1.03B1.03B564.21M1.37B3.88B4.03B
Total Liabilities1.76B1.76B1.18B2.25B4.54B4.90B
Stockholders Equity4.09B4.09B3.76B4.14B5.22B6.51B
Cash Flow
Free Cash Flow0-50.57M43.24M-130.81M-162.03M-1.38B
Operating Cash Flow051.41M95.83M-106.80M-6.75M869.16M
Investing Cash Flow0-98.03M-8.24M2.06B-213.70M-2.29B
Financing Cash Flow0460.79M-910.82M-2.51B-154.05M93.73M

Precision System Science Co.,Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price192.00

Price Trends

50DMA208.06Negative
100DMA206.92Negative
200DMA217.59Negative

Market Momentum

MACD-5.90Positive
RSI38.17Neutral
STOCH51.10Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Negative. The current price of 192.00 is below the 20-day moving average (MA) of 200.55, below the 50-day MA of 208.06, and below the 200-day MA of 217.59, indicating a bearish trend. The MACD of -5.90 indicates Positive momentum. The RSI at 38.17 is Neutral, neither overbought nor oversold. The STOCH value of 51.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7707.

Precision System Science Co.,Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7707 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4570JP:457077OutperformJPY 8.54B22.84―0.65%7.10%17.17%
JP:3386JP:338667NeutralJPY 7.12B21.17―4.07%7.17%36.23%
JP:7707JP:770761NeutralJPY 5.31B13.32―1.04%9.27%―
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4978JP:497844NeutralJPY 11.65B-25.06――-8.23%-48.10%
JP:4892JP:489242NeutralJPY 5.19B-6.32――364.72%18.43%
JP:7776JP:777637UnderperformJPY 6.70B-5.83――-49.43%-3.77%

* General Sector Average

Performance Comparison

0%100%200%300%JP:7707JP:3386JP:4570JP:4892JP:4978JP:7776Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7707 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7707Precision System Science Co.,Ltd192.00-12.00-5.88%
JP:3386Cosmo Bio Co., Ltd.1230.00-153.89-11.12%
JP:4570Immuno-Biological Laboratories Co., Ltd.917.0069.638.22%
JP:4892Cyfuse Biomedical K.K.514.00-67.00-11.53%
JP:4978ReproCELL Inc.109.00-48.00-30.57%
JP:7776CellSeed Inc.169.00-232.00-57.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 19, 2026